Background: The immediate-type allergic reaction is involved in many allergic diseases such as asthma, allergic rhinitis and sinusitis. The discovery of drugs for the treatment of immediate-type allergic disease is a very important subject in human health. Isodon japonicus Hara (Labiatae) (IJAE) has been used for centuries as a traditional medicine in Korea and is known to have an anti-inflammatory effect. However, its specific mechanism of action is still unknown. In this report, we investigated the effect of IJAE on the immediate-type allergic reaction and studied its possible mechanisms of action, focusing on the mast cell-mediated allergic reaction. Methods: IJAE extracts were anally administered to mice for high and fast absorption. Compound 48/80-induced mortality and compound 48/80- or immunoglobulin E (IgE)-induced histamine release were measured to evaluate the antiallergic effects of IJAE. The effect of IJAE on the model of local allergic reaction in vivo, passive cutaneous anaphylaxis (PCA), was investigated. The production of tumor necrosis factor-α (TNF-α) was measured by Western blotting. Results: IJAE inhibited compound 48/80-induced systemic reactions and plasma histamine release in mice. IJAE decreased the PCA reaction activated by anti-dinitrophenyl (DNP) IgE antibody. IJAE dose-dependently reduced histamine release from rat peritoneal mast cells activated by compound 48/80 or anti-DNP IgE. Furthermore, IJAE decreased the production of TNF-α in phorbol 12-myristate 13-acetate plus calcium ionophore A23187-stimulated human mast cells. Conclusion: Our findings provide evidence that IJAE inhibits mast cell-derived immediate-type allergic reactions, and also demonstrate the involvement of TNF-α in these effects. We propose the clinical use of IJAE in mast cell-mediated immediate-type allergic diseases.

Keywords:
Isodon japonicus, Allergic reaction, Compound 48/80, Anti-dinitrophenyl IgE, Tumor necrosis factor-α, Mast cells
1.
But PPH, Kimura T, Sung CK, Han BH: International Collation of Traditional Folk Medicine, ed 3. New Jersey, World Scientific, 1997, p 137.
2.
Nanba T: The Encyclopedia of Wakan-Yaku (Traditional Sino-Japanese Medicine) with Color Pictures, ed 2. Osaka, Hiokusha, 1994, p 18.
3.
Hwang BY, Lee JH, Koo TH, Kim HS, Hong YS, Ro JS, Lee KS, Lee JJ: Kaurane diterpenes from Isodon japonicus inhibit nitric oxide and prostaglandin E2 production and NF-kappa B activation in LPS-stimulated macrophage RAW264.7 cells. Planta Med 2001;67:406–410.
4.
Kim HM, Lee YM: Role of TGF-beta 1 on the IgE-dependent anaphylaxis reaction. J Immunol 1999;162:4960–4965.
5.
Metcalfe DD, Kaliner M, Donlon MA: The mast cell. Crit Rev Immunol 1981;3:23–74.
6.
Church MK, Levi-Schaffer F: The human mast cell. J Allergy Clin Immunol 1997;99:155–160.
7.
Petersen LJ, Mosbech H, Skov P: Allergen-induced histamine release in intact human skin in vivo assessed by skin microdialysis technique: Characterization of factors influencing histamine releasability. J Allergy Clin Immunol 1996;97:672–679.
8.
Lagunoff D, Martin TW, Read G: Agents that release histamine from mast cells. Annu Rev Pharmacol Toxicol 1983;23:331–351.
9.
Ennis M, Pearce FL, Weston PM: Some studies on the release of histamine from mast cells stimulated with polylysine. Br J Pharmacol 1980;70:329–334.
10.
Shin TY, Kim DK: Inhibitory effect of mast cell-dependent anaphylaxis by Gleditsia sinensis. Arch Pharm Res 2000;23:401–406.
11.
Beaven MA, Metzger H: Signal transduction by Fc receptors: The Fc epsilon RI case. Immunol Today 1993;14:222–226.
12.
Metzger H, Alcaraz G, Hohman R, Kinet JP, Pribluda V, Quarto R: The receptor with high affinity for immunoglobulin E. Annu Rev Immunol 1986;4:419–470.
13.
Alber G, Miller L, Jelsema C, Varin-Blank N, Metzger H: Structure-function relationships in the mast cell high affinity receptor for IgE. Role of the cytoplasmic domains and of the beta subunit. J Biol Chem 1991;266:22613–22620.
14.
Chen S, Gong J, Liu F, Mohammed U: Naturally occurring polyphenolic antioxidants modulate IgE-mediated mast cell activation. Immunology 2000;100:471–480.
15.
Saito H, Nomura Y: Screening methods for drug evaluation 3; in Suzuki L, Tanaka H, Yajima H, Fukuda H, Sezaki H, Koga K, Hirobe M, Nakajime T (eds): Pharmaceutical Research and Development. Tokyo, Hirokawa, 1989, p 22.
16.
Burd PR, Rogers HW, Gordon JR, Martin CA, Jayaraman S, Wilson SD, Dvorak AM, Galli SJ, Dorf ME: Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 1989;170:245–257.
17.
Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordon RP, Paul WE: Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature 1989;339:64–67.
18.
Gurish MF, Ghildyal N, Arm J, Austen KF, Avraham S, Reynolds DS, Stevens RL: Cytokine mRNA are preferentially increased relative to secretory granule protein mRNA in mouse bone marrow-derived mast cells that have undergone IgE-mediated activation and degranulation. J Immunol 1991;146:1527–1533.
19.
Bradding P, Feather IH, Wilson S, Bardin PG, Heusser CH, Holgate T, Howarth PH: Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J Immunol 1993;151:3853–3865.
20.
Wodnar-Filipowicz A, Heusser CH, Moroni C: Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature 1989;339:150–152.
21.
Galli SJ, Gordon JR, Wershil BK: Cytokine production by mast cells and basophils. Curr Opin Immunol 1991;3:865–872.
22.
Yi JM, Jeong HJ, Kim NS, Kim MS, Zheng C, Kim HM: Effect of Gahmiseunggal-Tang on immediate-type allergic reaction by anal therapy. Int J Orient Med 2001;2:47–53.
23.
Shin TY, Kim DK, Chae BS, Lee EJ: Antiallergic action of Magnolia officinalis on immediate hypersensitivity reaction. Arch Pharm Res 2001;24:249–255.
24.
Katayama S, Shionoya H, Ohtake S: A new method for extraction of extravasated dye in the skin and the influence of fasting stress on passive cutaneous anaphylaxis in guinea pigs and rats. Microbiol Immunol 1978;22:89–101.
25.
Shore PA, Burkhalter A, Cohn VH: A method for fluorometric assay of histamine in tissues. J Pharmacol Exp Ther 1959;127:182–186.
26.
Jippo-Kanemoto TJ, Kasugai T, Yamatodani A, Ushio H, Mochizuki T, Tohya K, Kimura M, Nishimura M, Kitamura Y: Supernormal histamine release and normal cytotoxic activity of beige (Chediak-Higashi syndrome) rat mast cells with giant granules. Int Arch Allergy Immunol 1993;100:99–106.
27.
Yurt RW, Leid RW, Austen KF: Native heparin from rat peritoneal mast cells. J Biol Chem 1977;252:518–521.
28.
Wershil BK, Mekori YA, Murakami T, Galli SJ: 125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. J Immunol 1987;139:2605–2614.
29.
Kemp SF, Lockey RF: Anaphylaxis: A review of causes and mechanisms. J Allergy Clin Immunol 2002;110:341–348.
30.
Mousli M, Bronner C, Bockaert J, Rouot B, Landry Y: Interaction of substance P, compound 48/80 and mastoparan with the alpha-subunit C-terminus of G protein. Immunol Lett 1990;25:355–357.
31.
Mousli M, Bronner C, Landry Y, Bockaert J, Rouot B: Direct activation of GTP-binding regulatory proteins (G-proteins) by substance P and compound 48/80. FEBS Lett 1990;259:260–262.
32.
Bueb JL, Mousli M, Bronner C, Rouot B, Landry Y: Activation of Gi-like proteins, a receptor-independent effect of kinins in mast cells. Mol Pharmacol 1990;38:816–822.
33.
Tasaka K, Mio M, Okamoto M: Intracellular calcium release induced by histamine releasers and its inhibition by some antiallergic drugs. Ann Allergy 1986;56:464–469.
34.
Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF: Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 1991;15:4220–4224.
35.
Sillaber C, Bevec D, Butterfield JH, Heppner C, Valenta R, Scheiner O, Kraft D, Lechner K, Bettelheim P, Valent P: Tumor necrosis factor alpha and interleukin-1 beta mRNA expression in HMC-1 cells: Differential regulation of gene product expression by recombinant interleukin-4. Exp Hematol 1993;21:1271–1275.
36.
Lee JH, Koo TH, Hwang BY, Lee JJ: Kaurane diterpene, kamebakaurin, inhibits NF-kappa B by directly targeting the DNA-binding activity of p50 and blocks the expression of antiapoptotic NF-kappa B target genes. J Biol Chem 2002;277:18411–18420.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.